Glenn Greenberg recent buys & sells (2015 Q1)
Brave Warrior Advisors
Brave Warrior Advisors Portfolio Changes
Purchase & sale details
- Portfolio value:
- $3.28B (+$403M)
- Previous value:
- $2.87B
- # of changes:
- 12
- New positions:
- 1
- Reported for:
- 31 Mar 2015 (Q1)
- Latest filing date:
- 15 May 2015
Brave Warrior Advisors has disclosed a total of 12 changes to the portfolio in the (2015 Q1) SEC report(s): increased the number of shares of 6, bought 1 totally new and decreased the number of shares of 5 position(s).
What stocks did Glenn Greenberg buy in 2015 Q1?
During 2015 Q1 Glenn Greenberg has bought 7 securities out of which top 5 purchases (by % change to portfolio) were (JPM) JPMorgan Chase & Co (added shares +15.74%), (SCHW) Charles Schwab Corp (added shares +8.47%), (MSFT) Microsoft Corp (added shares +21.67%), (HAL) Halliburton Company (added shares +34.41%) and (EQIX) Equinix Inc (added shares +3.45%).
What did Glenn Greenberg invest in during 2015 Q1?
In the 2015 Q1 report(s) the following changes have been made to the top investments: (VRX) Valeant Pharmaceuticals International Inc (reduced shares -4.07%), (ESRX) Express Scripts Holding Co (reduced shares -14.51%), (JPM) JPMorgan Chase & Co (added shares +15.74%), (SCHW) Charles Schwab Corp (added shares +8.47%) and (MSFT) Microsoft Corp (added shares +21.67%).
12 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
JPMORGAN CHASE & CO-CW18
|
new
|
$22.01
|
|
1.80%
|
2015 Q1
|
~0.25 years
|
||||
|
|
Halliburton Company
|
+34.41%
|
$43.88
|
-25.66%($32.62)
|
7.46%
|
2014 Q4
|
~0.50 years
|
||||
|
|
Microsoft Corp
|
+21.67%
|
$40.65
|
+1,213.24%($533.90)
|
7.73%
|
2013 Q3
|
~1.75 years
|
||||
|
|
JPMorgan Chase & Co
|
+15.74%
|
$60.58
|
+454.67%($336.02)
|
8.91%
|
2014 Q3
|
~0.75 years
|
||||
|
|
Charles Schwab Corp
|
+8.47%
|
$30.44
|
+195.88%($90.06)
|
8.54%
|
2013 Q2*
|
> 2 years
|
||||
|
|
Baker Hughes Inc
|
+4.76%
|
$63.58
|
|
0.73%
|
2014 Q4
|
~0.50 years
|
||||
|
|
Equinix Inc
|
+3.45%
|
$225.85
|
+330.94%($973.27)
|
6.27%
|
2014 Q2
|
~1.00 year
|
||||
|
|
Valeant Pharmaceuticals International Inc
|
-4.07%
|
$198.62
|
|
35.64%
|
2013 Q2*
|
> 2 years
|
||||
|
|
Primerica Inc
|
-10.07%
|
$50.90
|
+451.90%($280.92)
|
3.28%
|
2013 Q2*
|
> 2 years
|
||||
|
|
CIMPRESS NV
|
-10.52%
|
$84.38
|
-10.33%($75.66)
|
6.53%
|
2014 Q4
|
~0.50 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".